AA
56
15
FTI
71
-7
FAST
57
-3
MDLZ
32
-4
GOOG
57
-6
DD
53
-6
SIG
44
-3
GS
72
4
EXR
57
2
NOC
41
9
NWS
75
-4
D
40
2
AIV
64
4
CSX
57
-4
AAP
35
-9
TGNA
50
-6
KSS
39
-7
HRL
35
-3
IRM
41
3
ZTS
47
2
AA
56
15
FTI
71
-7
FAST
57
-3
MDLZ
32
-4
GOOG
57
-6
DD
53
-6
SIG
44
-3
GS
72
4
EXR
57
2
NOC
41
9
NWS
75
-4
D
40
2
AIV
64
4
CSX
57
-4
AAP
35
-9
TGNA
50
-6
KSS
39
-7
HRL
35
-3
IRM
41
3
ZTS
47
2
Financhill
Back

Allspring Utilities and High Income Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
39

ERH
Allspring Utilities and High Income Fund

Last Price:
10.75
Seasonality Move:
0.1%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
39
Allspring Utilities and High Income Fund (ERH) is a Sell

Is Allspring Utilities and High Income Fund a Buy, Sell or Hold?

  • The current Allspring Utilities and High Income Fund [ERH] share price is $10.75. The Score for ERH is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ERH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ERH Stock Price Chart

What is Allspring Utilities and High Income Fund's stock price today?

  • The Allspring Utilities and High Income Fund share price today is $10.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ERH is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ERH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 43.38 Sell
Chaikin Money Flow: -1331 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.76 - 11.18) Sell
Bollinger Bands (100): (10.15 - 11.07) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ERH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.74 Buy
20-day SMA: 10.92 Sell
50-day SMA: 10.99 Sell
200-day SMA: 10.01 Buy
8-day EMA: 10.77 Sell
20-day EMA: 10.87 Sell
50-day EMA: 10.86 Sell
200-day EMA: 10.28 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Allspring Utilities and High Income Fund Earnings Growth & ERH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Allspring Utilities and High Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):